Vireo Growth Inc. (OTCQX:VREOF) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants John Mazarakis - CEO & Co-Executive Chairman Tyson Macdonald - Chief Financial Officer Conference Call Participants Michael Kim - Zacks Small-Cap Research Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning, and welcome to the Vireo Growth Inc. Third Quarter 2025 Results Call. The company would like to remind everyone that today's conference call may contain forward-looking statements within the meaning of U.S. and Canadian securities laws.
Vireo Growth Inc. (OTCQX:VREOF) Q2 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants J. Tyson Macdonald - Chief Financial Officer John Michael Mazarakis - CEO & Co-Executive Chairman Conference Call Participants Pablo Ernesto Zuanic - Zuanic & Associates Sung-Chul Kim - Zacks Small-Cap Research Operator Good morning, and welcome to the Vireo Growth Inc.'s Second Quarter 2025 Results Call.
Vireo Growth Inc. (OTCQX:VREOF) Q4 2024 Earnings Conference Call March 4, 2025 8:30 AM ET Company Participants John Mazarakis - Co-Executive Chairman and Chief Executive Officer Tyson Macdonald - Chief Financial Officer Conference Call Participants Eric Des Lauriers - Craig-Hallum Capital Group Operator Good morning, and welcome to Vireo Growth Inc's. Fourth Quarter and Full Year 2024 Results Call.
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Joshua Nathaniel Rosen CEO | OTCQX Exchange | - ISIN |
| United States Country | 385 Employees | - Last Dividend | - Last Split | - IPO Date |
Vireo Growth Inc. is a dynamic entity in the cannabis industry within the United States, focusing on the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products. Formerly known as Goodness Growth Holdings, Inc., the company underwent rebranding to Vireo Growth Inc. in July 2024, aligning its corporate identity with its expansion and broadening vision. Based in Minneapolis, Minnesota, Vireo Growth makes its mark by offering a wide array of cannabis products, catering to both medical patients and recreational consumers across Maryland, Minnesota, and New York through its Green Goods and other Goodness Growth branded retail dispensaries, as well as through third-party dispensaries. The strategic positioning of its operations underscores the company's commitment to quality, innovation, and accessibility in the burgeoning cannabis market.
These products focus on fulfilling the needs of patients with various health conditions. Utilizing advanced cultivation and manufacturing processes, Vireo Growth Inc. produces a diverse range of medical cannabis products, including but not limited to, tinctures, capsules, and vaporizable oils. These products are designed for patients seeking relief from specific medical conditions, ensuring they receive the therapeutic benefits of cannabis with consistent quality and efficacy.
Targeted at the recreational market, adult-use cannabis products by Vireo Growth cater to consumers looking for premium cannabis experiences. The range includes a variety of forms such as flowers, pre-rolled joints, edibles, and concentrates, providing a broad spectrum of options for recreational use. By prioritizing safety, purity, and potency, these products aim to meet the diverse preferences and tastes of adult consumers.
Vireo Growth expands its reach and accessibility through a strategic network of retail dispensaries, including Green Goods and other Goodness Growth branded stores, along with third-party dispensaries. This extensive distribution network ensures that both medical and recreational consumers have convenient access to their wide range of cannabis products, regardless of their location in Maryland, Minnesota, and New York. By offering an inviting in-store experience and knowledgeable staff, Vireo Growth aims to educate customers, while providing a safe and welcoming environment for purchasing cannabis products.